Wednesday, March 27, 2024Wednesday, 27 March 2024 - ET (Eastern Time, GMT-05:00)

Showing 1 of 1 Streams

Plenary

6:00am - 6:45am

Fun Run/Walk

Showing 2 of 2 Streams

Solution Summit

Networking Break

8:00am - 8:30am

Solution Summit- Beyond Automation: How BlackLine Enables Achievable Change

When asked what would help their companies respond to disruption, CFOs agree the ability to access and analyze financial data in real time is critical. However, 37% admit they do not entirely trust their data.

For F&A leaders, it’s evident transformation can unlock value for their organizations, but the challenge is deciding where to begin and how to develop and execute an achievable plan.

In this session, you’ll explore the value of having a transformation foundation built on efficient, reliable actuals and how you can get started. We’ll also cover how to:

· Build a business case based on your business model and priorities

· Adopt leading practices that are comprehensive, flexible, and scalable

· Leverage technology like BlackLine to unify data and processes and streamline and automate manual processes like reconciliations, journal entries, and variance analyses

Michael Gilmartin - Global Vice President, Value Architecture and SAP Center of Excellence, BlackLine

8:00am - 8:30am

Breakfast

Showing 2 of 2 Streams

Industry Only Round Table

Accounting Bootcamp

8:30am - 10:30am

Industry Only Round Table

Sandra Patterson - Senior Vice President, Corporate Controller and Chief Accounting Officer, Gilead Sciences
Timothy Kocses - Executive Director, US Commercial Controller, Bristol Myers Squibb
Jovita Nwosu - Director, Accounting Standards, Merck
Stephen Rivera - Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
Kevin Mackay - Vice President, Global Technical Accounting Advisory Services & Policy, Pfizer

8:30am - 10:30am

Accounting Bootcamp

Deloitte leaders provide an overview of hot topics facing the finance and accounting professionals in the life sciences industry. Discussion topics include:

Overview of key updates to Deloitte’s Life Sciences Industry Accounting Guide (March 2024)
ESG: Regulatory Reporting Preparedness in the Life Sciences Industry
Generative AI within the Finance Function
IPO Readiness and Capital Markets Transactions

Kara Seamon - Senior Manager, Deloitte & Touche LLP
BJ Spence - Partner, Deloitte & Touche LLP
James O'Mahony - Senior Manager, Deloitte & Touche LLP
Dan Hummel - Senior Manager, Deloitte & Touche LLP
Michelle Gura - Senior Manager, Deloitte & Touche LLP
Tasia Blazevich - Managing Director, Deloitte & Touche LLP

Showing 1 of 1 Streams

Plenary

10:30am - 11:00am

Networking Break

11:00am - 11:15am

Chairperson’s Review of Day One

Stephen Rivera - Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson

11:15am - 12:00pm

Insights from the CFO

Nick Cernese - Global Health Sciences & Wellness Consulting Partner, Ernst & Young
Lea Knight - EVP and Chief Financial Officer, Integra LifeSciences
Justin Renz - Chief Financial Officer, Ardelyx
Jeff Caravella - Business Development- Interventional Oncology, Johnson & Johnson

12:00pm - 1:00pm

Confronting the change imperative: how a fresh look at diversity oversight can impact the business strategy

Laura Robinette - US Health Industries Leader, Partner, PwC
Stephen Rivera - Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
Jovita Nwosu - Director, Accounting Standards, Merck
Sandra Patterson - Senior Vice President, Corporate Controller and Chief Accounting Officer, Gilead Sciences
Thomas Spoerel - SVP, Finance, Chief Accounting Officer, & CFO-International, BD

1:00pm - 2:00pm

Luncheon & Trail Blazer Awards

Showing 3 of 3 Streams

Large Company Track

Small Company Track

Operational Excellence

2:00pm - 2:45pm

Increasing Working Capital

Fran Dougherty - Vice President of Finance, Johnson & Johnson
Thomas Spoerel - SVP, Finance, Chief Accounting Officer, & CFO-International, BD
Robert Dunn - Vice President, Head of Global Commercial Finance, QuidelOrtho
Thomas Zerbo - Global Transaction Services Advisory, Bank of America

2:45pm - 3:30pm

General Audit & Tax Planning – Overview of the Technical Accounting and SEC Standards

Robert Auslander - Vice President, Internal Audit, Bausch & Lomb
Trevor Ackerman - VP, Global Tax, Amneal Pharmaceuticals
Anna Simansky - VP, Global Audit Services, Zimmer Biomet
James Engel - Controller, Finance, Collegium Pharmaceuticals

2:00pm - 2:45pm

Product Launch Readiness: Accounting policy, operational accounting, and financial reporting considerations for first time commercialization

Phil Howard - West FAAS Health Sciences and Wellness Market Segment Leader, Ernst & Young
Ashish Mandelia - Vice President, Chief Accounting Officer, Mersana Therapeutics
Angelina Pigna - Senior Director, Commercial Accounting, Mirati Therapeutics, A Bristol-Myers Squibb Company
Scott Sieckert - VP, Finance, Tarsus Pharmaceuticals
Dave McLennan - VP, Finance, IntraBio

2:45pm - 3:30pm

GTN Frameworks

Patrizio Calitri - Global CoE, Office of Finance Lead Board International, Board Americas, Board Americas
Nick Olivares - Controller, Lundbeck
Brett Nussbaum - Director of Gross to Net Accounting, Novartis
Rohit Gupta - Director, Global Revenue Finance, Pfizer

2:00pm - 2:45pm

Workforce Transformation -- Building Strong and Sustainable Finance and Accounting Teams

Mike Moïse - Associate Director, Life Sciences, CrossCountry Consulting
Mallory Morales - Chief Accounting Officer, Immuneering
Scott Doelger - Vice President, Financial Reporting & Accounting, Bristol-Myers Squibb
Kevin Nee, CPA, MSA - Controller, Collegium Pharmaceutical, Inc.
Erin Burkhart - Group Vice President and Chief Accounting Officer, BioMarin Pharmaceutical

2:45pm - 3:30pm

Optimizing Strategy through a Business-Centric R&D Structure

Jennifer Kyle - Founder and CEO, Condor Software
Thomas Cunningham - Assistant Controller, Merck
Mark Lynch - Sr. Director, Global Technical Accounting Service & Policy, Johnson & Johnson

Showing 1 of 1 Streams

Plenary

3:30pm - 4:00pm

Networking Break

Showing 3 of 3 Streams

Large Company Track

Small Company Track

Operational Excellence

4:00pm - 4:45pm

Overview of the Close Process – Getting to a Zero Day Close

Ryan McNally - Senior Manager, Crowe LLP
Chris Kimtis - Director, Corporate Financial Reporting, Bristol-Myers Squibb
Jeff Miller - Corporate Controller, Lannett Pharmaceuticals
Chaz Simpson - Managing Director, Crowe LLP
Jeff Driggs - VP Technical Accounting & Reporting, Kenvue

4:45pm - 5:30pm

Inflation Reduction Act: Implementing New Changes Brought on by Legislation in 2024

Timothy Kocses - Executive Director, US Commercial Controller, Bristol Myers Squibb
Ryan Clements - Managing Director, KPMG

4:00pm - 4:45pm

Managing R&D Spend: Scaling Data, Processes and Controls

Erin Warner Guill - President and Chief Operating Officer, Auxilius

4:45pm - 5:30pm

Cash Preservation – Key Considerations for Scaling the Business

Josias Pontes - Former Chief Financial Officer, Sigilon
Mallory Morales - Chief Accounting Officer, Immuneering

4:00pm - 4:45pm

Shared Services: Balancing and maintaining outsourcing, internal functions, and automation

Jennifer Finger - Partner, Transactions and Financial Advisory I CFO Advisory, Baker Tilly
Kelly Palumbo - Corporate Vice President, Finance, Corporate Controller, Charles River Laboratories
Michael Clark - Corporate Controller, Executive Director, Legend Biotech

4:45pm - 5:30pm

Executive Think Tank

This open forum allows for senior level executives to exchange ideas and best practices for driving internal and organizational success through efficiencies, technology, and new innovations.

*Informa Connect reserves the right to qualify participants for this Summit. Attendees must be a Director/Senior Director/VP with 10+ years experience and currently employed by a life sciences manufacturer.

Showing 1 of 1 Streams

Plenary

5:30pm - 6:30pm

Networking Reception